Results 71 to 80 of about 8,320 (205)

Factor XI and coagulation. Factor XI inhibitors - antithrombotic perspectives

open access: yesRomanian Journal of Internal Medicine
Factor XI is a zymogen with an important role in the coagulation cascade. It is activated by FXII, thrombin and or it can be autoactivated. It has a prothrombotic effect after being activated by thrombin, but also through its antifibrinolytic action ...
Vlădăreanu Ana-Maria, Roşca Adrian
doaj   +1 more source

Efeito da vacinação estreptocócica sobre a produção de antiestreptofibrinolisina

open access: yesMemorias do Instituto Oswaldo Cruz, 1946
The vaccination with hemolytic streptococci washed in saline doesn't give to the plasma of vaccinated people resistence against fibrinolysis, when in presence of antistreptofibrinolysin. The A. A.
J. Guilherme Lacorte, Mario Santos
doaj   +1 more source

Tranexamic Acid Treatment of Life-Threatening Hematuria in Polycystic Kidney Disease

open access: yesInternational Journal of Nephrology, 2011
A 41-year-old woman with autosomal dominant polycystic kidney disease had chronic kidney disease class IV. She presented 10 days postpartum with a 4-day history of severe hematuria, left flank pain, and anemia, hemoglobin 62 g/L. CT scan showed massively
Turki AlAmeel, Michael West
doaj   +1 more source

Accidental Intrathecal Injection of Tranexamic Acid

open access: yesCase Reports in Anesthesiology, 2012
Tranexamic acid (TXA) is a popular antifibrinolytic drug that is commonly used in patients with bleeding disorder. Major morbidities and mortalities have been reported following inadvertent intrathecal injection of TXA.
Khaled Mahmoud, Amany Ammar
doaj   +1 more source

Antifibrinolytics and current anaesthetic [PDF]

open access: yesBritish Journal of Anaesthesia, 2014
S. Jagannathan, M.H. Davies
openaire   +3 more sources

Home - About - Disclaimer - Privacy